181 related articles for article (PubMed ID: 1528302)
21. Antigens on human plasma cells identified by monoclonal antibodies.
Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
[TBL] [Abstract][Full Text] [Related]
22. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
23. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
24. Cell surface antigens expressed by subsets of pre-B cells and B cells.
McKearn JP; Baum C; Davie JM
J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
[TBL] [Abstract][Full Text] [Related]
25. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
Howard DR; Eaves AC; Takei F
Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
Kikuchi K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
[TBL] [Abstract][Full Text] [Related]
27. A unique DR-related B cell differentiation antigen.
Shipp MA; Schwartz BD; Kannapell CC; Griffith RC; Scott MG; Ahmed P; Davie JM; Nahm MH
J Immunol; 1983 Nov; 131(5):2458-67. PubMed ID: 6415171
[TBL] [Abstract][Full Text] [Related]
28. [Stages of B-lymphocyte differentiation in acute lymphoblastic leukemia].
Koehler M; Bubała H; Sońta-Jakimczyk D; Guzikowska E; Janik-Moszant A; Wieczorek M; Hołowiecki J
Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):879-81, 884. PubMed ID: 2487942
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
30. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
31. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line.
Gougos A; Letarte M
J Immunol; 1988 Sep; 141(6):1925-33. PubMed ID: 3262644
[TBL] [Abstract][Full Text] [Related]
32. B5, a new B cell-restricted activation antigen.
Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
[TBL] [Abstract][Full Text] [Related]
34. SC3 monoclonal antibody defines a novel specific human B-cell surface antigen differentially expressed on B-cell leukaemias and lymphomas and involved in the proliferation of normal and malignant B lymphocytes.
Nikolova M; Guenova M; Taskov H; Marie-Cardine A; Boumsell L; Bensussan A
Cell Immunol; 2005; 236(1-2):92-100. PubMed ID: 16197933
[TBL] [Abstract][Full Text] [Related]
35. Normal and neoplastic plasma cell membrane phenotype: studies with new monoclonal antibodies.
Tazzari PL; Gobbi M; Dinota A; Bontadini A; Grassi G; Cerato C; Cavo M; Pileri S; Caligaris-Cappio F; Tura S
Clin Exp Immunol; 1987 Oct; 70(1):192-200. PubMed ID: 3319299
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
[TBL] [Abstract][Full Text] [Related]
37. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
38. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
Norton AJ; Isaacson PG
Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
[TBL] [Abstract][Full Text] [Related]
39. Distribution of a new B-cell-associated surface antigen (BL7) detected by a monoclonal antibody in human leukemic disorders.
Al-Katib A; Wang CY; Koziner B
Cancer Res; 1985 Jul; 45(7):3058-63. PubMed ID: 3924396
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia.
Campana D; Farrant J; Inamdar N; Webster AD; Janossy G
J Immunol; 1990 Sep; 145(6):1675-80. PubMed ID: 2391416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]